Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Infection ; 33(2): 73-6, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15827874

RESUMEN

BACKGROUND: Information on strain types of human cytomegalovirus (HCMV) isolates from Saudi Arabian patients is lacking. MATERIALS AND METHODS: 80 clinical isolates of HCMV from Saudi Arabian patients were analyzed by PCR amplification of three regions (DNA polymerase, glycoprotein B, and glycoprotein H) of the virus genome. The resultant amplicons (2.0-2.7 kb) were further studied by restriction fragment length polymorphism (RFLP) using four enzymes (HaeIII, HhaI, MspI, and RsaI). RESULTS: Combined analysis of the cleavage patterns generated by the enzymes identified five strains, S1-S5, and several mixed and unique strains. 18 isolates belonged to S1 strain and were similar to laboratory strain AD169. Eight isolates were present in each of S2 and S3 strains. Six isolates and four isolates were found in S4 and S5 strains, respectively. 12 isolates contained a mixture of S3 and S5, which may have resulted from a dual infection. Each of the 24 remaining isolates had a different strain pattern. CONCLUSION: Our findings show that 80 HCMV clinical isolates were distributed into 30 different strains using PCRRFLP analysis of multiple viral subgenomic regions. However, the number of isolates is not uniformly distributed among strains (p < 0.02).


Asunto(s)
Citomegalovirus/clasificación , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Longitud del Fragmento de Restricción , Citomegalovirus/genética , Infecciones por Citomegalovirus/epidemiología , Infecciones por Citomegalovirus/virología , Genes Virales , Variación Genética , Humanos , Arabia Saudita/epidemiología
2.
J Clin Microbiol ; 38(12): 4569-76, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11101597

RESUMEN

A 12-year-old girl with acute lymphoblastic leukemia was referred to King Faisal Specialist Hospital and Research Center. The diagnosis without central nervous system (CNS) involvement was confirmed on admission, and chemotherapy was initiated according to the Children Cancer Group (CCG) 1882 protocol for high-risk-group leukemia. During neutropenia amphotericin B (AMB) (1 mg/kg of body weight/day) was initiated for presumed fungal infection when a computed tomography (CT) scan of the chest revealed multiple nodular densities. After 3 weeks of AMB therapy, a follow-up chest CT revealed progression of the pulmonary nodules. The patient subsequently suffered a seizure, and a CT scan of the brain was consistent with infarction or hemorrhage. Because of progression of pulmonary lesions while receiving AMB, antifungal therapy was changed to liposomal AMB (LAMB) (6 mg/kg/day). Despite 26 days of LAMB, the patient continued to have intermittent fever, and CT and magnetic resonance imaging of the brain demonstrated findings consistent with a brain abscess. Aspiration of brain abscess was performed and the Gomori methenamine silver stain was positive for hyphal elements. Culture of this material grew Acrophialophora fusispora. Lung biopsy showed necrotizing fungal pneumonia with negative culture. The dosage of LAMB was increased, and itraconazole (ITRA) was added; subsequently LAMB was discontinued and therapy was continued with ITRA alone. The patient demonstrated clinical and radiological improvement. In vitro, the isolate was susceptible to low concentrations of AMB and ITRA. A. fusispora is a thermotolerant, fast-growing fungus with neurotropic potential. We report the first case of human infection involving the CNS. Acrophialophora resembles Paecilomyces but differs in having colonies that become dark and in the development of phialides along the sides or at the tips of echinulate brown conidiophores. Conidia are borne in long chains and are smooth or ornamented with fine-to-coarse echinulations, sometimes in spiral bands. The taxonomy of the genus Acrophialophora is reviewed, and Acrophialophora nainiana and Acrophialophora levis are considered as synonyms of A. fusispora.


Asunto(s)
Absceso Encefálico/microbiología , Hongos Mitospóricos/clasificación , Leucemia-Linfoma Linfoblástico de Células Precursoras/microbiología , Absceso Encefálico/patología , Niño , Femenino , Humanos , Pruebas de Sensibilidad Microbiana , Hongos Mitospóricos/efectos de los fármacos , Hongos Mitospóricos/aislamiento & purificación , Leucemia-Linfoma Linfoblástico de Células Precursoras/patología
3.
J Med Liban ; 48(4): 227-32, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11214194

RESUMEN

Due to modern travel and ease of spread of infections, it is desirable to widen knowledge of susceptibility of common bacterial isolates from different parts of the world for optimal clinical management and control programs. Over the past decades, antimicrobial resistance has emerged in all kinds of micro-organisms worldwide including Saudi Arabia. This phenomenon is primarily due to increasing antibiotic use and misuse in humans, animals and agriculture. Additionally, the presence of a large expatriate population and a significant number of visitors to the Kingdom annually for pilgrimage and/or work from all over the world may have also facilitated the importation to Saudi Arabia of drug resistant micro-organisms from other countries. Saudi Arabia has witnessed an increase of drug resistant Mycobacterium tuberculosis, Streptococcus pneumoniae, Staphylococcus aureus and some Enterobacteriaceae in the last decade. We describe the status of antimicrobial resistance in Saudi Arabia which is an important focus of antimicrobial resistance for the Gulf Region.


Asunto(s)
Infecciones Bacterianas/epidemiología , Infecciones Bacterianas/microbiología , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/microbiología , Farmacorresistencia Microbiana , Antibacterianos/efectos adversos , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Enfermedades Transmisibles Emergentes/tratamiento farmacológico , Utilización de Medicamentos , Humanos , Pruebas de Sensibilidad Microbiana , Vigilancia de la Población , Arabia Saudita/epidemiología
4.
Ther Drug Monit ; 21(6): 647-52, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10604827

RESUMEN

The authors describe a simplified high-performance liquid chromatographic (HPLC) method for the determination of gentamicin sulfate (GEN) in microsamples of plasma using 9-fluorenylmethyl chloroformate (FMOC) as a derivatizing agent and neomycin sulfate as the internal standard (IS). The drug and IS were separated on a 4 microm (particle size), 8 x 100 mm Nova-Pak C18 radial compression cartridge using a mixture of 84.5% acetonitrile and 15.5% water at a flow rate of 2.5 mL/min. The compounds were detected fluorometrically in the effluent at excitation and emission wavelengths of 260 nm and 315 nm, respectively. Sample preparation was performed on 50 microL of plasma using a simple liquid-liquid extraction followed by a room-temperature derivatization procedure. No interference from any endogenous substance or concurrently used drug was observed, and the retention times of the IS and three major components of GEN were 12.4, 19.5, 23.6, and 27.6 min, respectively. The concentration of the GEN in plasma for the range of 0.2-20.0 microg/mL was linearly (r > .997) related to the peak height ratio of the sum of the three major GEN peaks to that of the IS, with CV value at 0.3, 7.5, and 15 microg/mL being <3.61%. A comparison of the results from this assay versus fluorescence polarization immunoassay (TDx) showed a close agreement between the two methods with r = 0.994. This assay is currently being used to monitor GEN and investigate its pharmacokinetics in pediatric patients.


Asunto(s)
Gentamicinas/sangre , Cromatografía Líquida de Alta Presión , Reacciones Cruzadas , Fluorenos , Fluorescencia , Inmunoensayo de Polarización Fluorescente , Humanos , Indicadores y Reactivos , Microquímica , Sensibilidad y Especificidad , Temperatura
5.
Ann Saudi Med ; 19(1): 62-3, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-17337991
6.
Saudi Med J ; 20(3): 232-5, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27614597

RESUMEN

Full text is available as a scanned copy of the original print version.

7.
Saudi Med J ; 20(7): 551, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27632463

RESUMEN

Full text is available as a scanned copy of the original print version.

9.
Am J Perinatol ; 15(11): 643-8, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10064206

RESUMEN

Liposomal amphotericin B (L-Amp B), a novel formulation of amphotericin B, is effective for the treatment of invasive fungal infections in children and adults and is associated with less toxicity than the conventional preparation. Data on the use of Liposomal amphotericin B in neonates is scarce. We describe the clinical course of two premature infants who were treated with Liposomal amphotericin B (one infant had candidemia, and the other had candidemia and meningitis), and provide a summary of previously published experience on this topic. Liposomal amphotericin B may be an option for therapy of invasive candidiasis in neonates who are at high risk of nephrotoxicity and other amphotericin-related reactions, but clinical trials are necessary to document its safety and efficacy in this age group.


Asunto(s)
Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Candidiasis/tratamiento farmacológico , Enfermedades del Prematuro/tratamiento farmacológico , Recien Nacido Prematuro , Portadores de Fármacos , Humanos , Recién Nacido , Liposomas , Masculino
10.
Am J Perinatol ; 14(9): 573-6, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9394170

RESUMEN

Liposomal amphotericin B L-Amp B, a novel formulation of Amp B, is effective for the treatment of invasive fungal infections in children and adults and is associated with less toxicity than the conventional preparation. Data on the use of L-Amp B in neonates is scarce. We describe the clinical course of two premature infants who were treated with L-Amp B (one infant had candidemia, and the other had candidemia and meningitis), and provide a summary of previously published experience on this topic. L-Amp B may be an option for therapy of invasive candidiasis in neonates who are at high risk of nephrotoxicity and other amphotericin-related reactions, but clinical trials are necessary to document its safety and efficacy in this age group.


Asunto(s)
Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Candidiasis/tratamiento farmacológico , Enfermedades del Recién Nacido/tratamiento farmacológico , Enfermedades del Recién Nacido/microbiología , Recien Nacido Prematuro , Portadores de Fármacos , Resultado Fatal , Humanos , Recién Nacido , Liposomas , Masculino
11.
Ann Saudi Med ; 17(2): 151-3, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17377419
12.
Eur J Clin Pharmacol ; 52(4): 255-60, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9248761

RESUMEN

OBJECTIVE: Based on the guidelines of the United States Joint Commission for Accreditation of Health Care Organizations for conducting a drug utilization evaluation, we evaluated the usage of intravenous immune globulin at our tertiary care hospital. METHODS: An initial concurrent evaluation of IVIG use showed deficiencies in both dosing and compliance with hospital policy, with regards to its use for unlabeled indications. Two follow-up evaluations were performed after the institution of an IVIG indication form, which was designed to accompany each order. RESULTS: We demonstrated consistent improvements in both dosing criteria, labeled IVIG use, and compliance with hospital policy its use in unlabeled indications. An ongoing prospective program targeting IVIG use, combined with the introduction of a simple indication form improved its utilization at our hospital.


Asunto(s)
Revisión de la Utilización de Medicamentos , Inmunoglobulinas Intravenosas/uso terapéutico , Etiquetado de Medicamentos , Estudios de Seguimiento , Humanos , Guías de Práctica Clínica como Asunto , Estudios Prospectivos , Arabia Saudita
13.
Ann Saudi Med ; 17(6): 587-9, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17338001
15.
Ann Saudi Med ; 16(5): 495-6, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17429223
17.
Eur J Pediatr ; 155(3): 173-4, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8929722

RESUMEN

UNLABELLED: We describe a newborn with cyanotic congenital heart disease who developed severe cortical hyperostosis of his long bones simulating osteomyelitis with remarkable elevation of alkaline phosphatase on the 11th day of prostaglandin E1 (PGE1) infusion. Soft tissue swelling and tenderness disappeared 6 days after discontinuation of PGE1, however alkaline phosphatase remained high. CONCLUSION: To our knowledge this is the first reported case that presented with such an acute complication of PGE1 therapy within a short period.


Asunto(s)
Alprostadil/efectos adversos , Conducto Arterioso Permeable/tratamiento farmacológico , Cardiopatías Congénitas/tratamiento farmacológico , Hiperostosis Cortical Congénita/inducido químicamente , Osteomielitis/diagnóstico por imagen , Alprostadil/administración & dosificación , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Conducto Arterioso Permeable/diagnóstico por imagen , Peroné/diagnóstico por imagen , Cardiopatías Congénitas/diagnóstico por imagen , Humanos , Hiperostosis Cortical Congénita/diagnóstico por imagen , Recién Nacido , Infusiones Intravenosas , Masculino , Radiografía , Tibia/diagnóstico por imagen
18.
Ann Saudi Med ; 16(1): 16-9, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-17372395

RESUMEN

The hematologic, histologic and morphologic bone marrow findings of 18 patients with human immunodeficiency virus (HIV) infection were reviewed. The mean age of the patients studied was 27 years; age range was six to 63 years. The main bone marrow morphologic finding was hypercellularity (72%), which was mainly due to megakaryocytic hyperplasia with or without granulocytic or erythrocytic hyperplasia. Naked (denuded) megakaryocytic nuclei, which are considered an indicator of HIV infection, were present in 72% of the bone marrows examined. Reticuloendothelial iron blockade was identified in 78% of cases. Other less frequent findings included erythrocytic dysplasia (44%), plasmacytosis (28%), nonspecific granulomas (17%), Hodgkin's and non-Hodgkin's lymphoma (17%), lymphocytic aggregates (11%) and histiocytosis (6%) . The bone marrow findings in this series of HIV patients appear to be similar to what has been previously reported from other countries.

19.
Pediatr Infect Dis J ; 14(10): 895-9, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8584319

RESUMEN

National committees recommend annual influenza vaccination for children > or = 6 months of age with chronic pulmonary diseases, but several studies have suggested that many high risk children do not receive the vaccine. The purpose of this pilot study was to determine whether the use of structured guidelines for which pulmonary disorders warrant influenza vaccination would increase agreement among physicians on whether specific children should be vaccinated. Hospital records of 73 children with an outpatient appointment during the previous month in the pulmonary, allergy or high risk neonatology clinics were reviewed independently by 4 pediatricians. Two reviewers used a set of specific guidelines in deciding whether influenza vaccination was indicated, whereas the other 2 used unspecified clinical judgment. Interrater agreement concerning the advisability of vaccination was higher between the reviewers using the guidelines (overall agreement, 0.89; kappa = 0.73) than between the reviewers using clinical judgment (overall agreement, 0.68; kappa = 0.31). Even among the 34 children for whom all 4 reviewers thought the vaccine advisable, only 13 (38%) had been vaccinated. Studies to define the risk of severe influenza among children with specific lung disorders are needed, but these guidelines can serve as a starting point for the identification of children who deserve individual consideration for annual influenza vaccination.


Asunto(s)
Vacunas contra la Influenza/uso terapéutico , Gripe Humana/prevención & control , Enfermedades Pulmonares , Guías de Práctica Clínica como Asunto , Niño , Preescolar , Enfermedad Crónica , Humanos , Lactante , Proyectos Piloto , Factores de Riesgo
20.
Ann Saudi Med ; 15(1): 84, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17587914
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA